Product Information
CIMETIDINE 800 MG TABLET is a generic product labeled by Bionpharma Inc., priced at $0.7208 per EA under NDC 69452032620. Its NADAC has been published 53 times since Oct 1, 2025.
FDA first approved this application on Nov 7, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
800 mg/1
Manufacturer
Bionpharma Inc.NDC
69452032620
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CIMETIDINEApproval Type
Generic (ANDA)
FDA Application
ANDA218220FDA Approved
11/7/2024
TE Code
AB
On Market Since
3/1/2025
Pharmacological Classes
Price Statistics
The NADAC for CIMETIDINE 800 MG TABLET has been published 53 times since Oct 1, 2025, and over the history we have for it it has declined 16.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7208 per EA |
|---|---|
| All-time high | $0.8649 (Oct 15, 2025) |
| All-time low | $0.7208 (Sep 23, 2026) |
| 52-week high | $0.8649 |
| 52-week low | $0.7208 |
| Median price | $0.7938 |
| Average price | $0.7930 |
| Largest weekly change | -3.9% (Aug 19, 2026) |
| Weeks tracked | 53 |
| Tracking since | Oct 1, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bionpharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
cimetidine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-2 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CIMETIDINE 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CIMETIDINE 800 MG TABLET, manufactured by Bionpharma Inc., is $0.7208 per EA (NDC 69452032620), effective Sep 30, 2026.
How has the price of CIMETIDINE 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for CIMETIDINE 800 MG TABLET has declined 16.7%. It has been tracked across 53 weekly CMS publications since Oct 1, 2025.
What are the highest and lowest recorded NADAC prices for CIMETIDINE 800 MG TABLET?
Since Oct 1, 2025, the NADAC for CIMETIDINE 800 MG TABLET has ranged from a low of $0.7208 (Sep 23, 2026) to a high of $0.8649 (Oct 15, 2025), with a median of $0.7938 per EA.
Are there cheaper alternatives to CIMETIDINE 800 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CIMETIDINE 800 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CIMETIDINE 800 MG TABLET?
CIMETIDINE 800 MG TABLET (NDC 69452032620) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.